David Steensma: Examining H3B-8800 for Myeloid Neoplasms

David Steensma, MD, discusses the results and unanswered questions raised by the first-in-human trial of the splicing modulator in patients with acute myeloid leukemia, chronic myelomonocytic leukemia, or myelodysplastic syndromes.